# NUPLAZID

NDC: 63090-340
Generic name: pimavanserin tartrate
Labeler / Manufacturer: Acadia Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20180628

FDA application: NDA210793

## Active ingredients

- PIMAVANSERIN TARTRATE: 34 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63090-340"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63090-340
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e6bea44-57d6-4bac-9328-46e1ee59f83b